Clinical trials
Phase 3 Schizophrenia trials in the United Kingdom
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
21 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2004 | 4 |
| 2007 | 2 |
| 2010 | 3 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2016 | 1 |
| 2017 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 18 |
| Terminated | 2 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Janssen-Cilag International NV | 4 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 3 |
| Alkermes, Inc. | 2 |
| Boehringer Ingelheim | 2 |
| FORUM Pharmaceuticals Inc | 2 |
| Hoffmann-La Roche | 2 |
| Karuna Therapeutics, Inc., a Bristol Myers Squibb company | 2 |
| AstraZeneca | 1 |
| GlaxoSmithKline | 1 |
| Janssen-Cilag Ltd. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Schizophrenia | 21 |
| Psychotic Disorders | 6 |
| Cognition Disorders | 2 |
| Body Weight Changes | 1 |
| Recurrence | 1 |
Trials
Showing 1 to 21 of 21. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.